Ondansetron was prescribed if they fulfilled the following inclusion criteria: (a) good response to MTX (reduction in the number of tender and swollen joints syndrome was observed during the course of chronic as well as in joint pain, along with improvement in the hepatitis C infection in the absence of antiviral overall disease activity as assessed by the physician therapy. Interferon-a therapy of chronic hepatitis C and the patient) in the absence of other side-effects; was followed by a complete biochemical and virolo-(b) severe nausea by MTX according to a graded gical response, along with dramatic improvement of analogue scale (none, 0; mild, 1; moderate, 2; severe, the thrombotic disease. In addition, the relapse of 3); (c) refractory nausea for at least 4 weeks despite viral hepatitis was immediately accompanied by a taking metoclopramide (10 mg/8 h), and switching recurrence of thrombotic disease. These findings sugfrom oral to i.m. MTX. MTX was given at the minimal gest that antiphospholipid thrombosis syndrome dose (7.5-15 mg/week orally in a single dose) to conmight be another HCV-associated autoimmune distrol RA activity. To minimize a possible effect related ease. In addition, both the concomitant response in to MTX, the dosage was maintained unchanged for at levels of ACA and HCV RNA clearance under least 4 weeks before the onset of ondansetron and interferon treatment led to the remission of the during the 24 weeks of follow-up. Leucovorin was thrombotic disease, as has been described with other given for at least 8 weeks before starting with ondanseimmunological disorders related to HCV infection [4] . tron therapy at a standardized dosage: 2.5 mg 24 h protocol that included the most important adverse effects previously attributed to ondansetron: headache, 1 2 6 9 6 2 3 0 0 3 *Nausea intensity: none, 0; mild, 1; moderate, 2; severe, 3. †The duration was considered as the number of hours of nausea after MTX was taken.
related to ondansetron were written in a diary daily follow-up ( Table I ) . At the end of the study, mild nausea persisted in 3/9 patients. In these three cases, by the patients. Activity due to RA was examined at baseline and at each visit after ondansetron therapy. the duration of nausea was reduced. Ondansetron therapy did not modify the activity of RA and no Full blood count, ESR, blood chemistry profile and urinalysis were performed monthly. A comparative adverse effects were found. Despite our study being uncontrolled, ondansetron study of the intensity and duration of nausea at baseline (considered as the symptoms observed a week seems to be effective since all our patients showed a dramatic improvement in both the duration and before onset of ondansetron therapy) with observations at 1, 4, 8, 16 and 24 weeks was performed. A nonintensity of nausea. This improvement occurred shortly after the first week of therapy and was parametric analysis of the variance for related samples ( Friedman's test) was applied. Statistical significance maintained during the 24 weeks of follow-up. However, concern may arise considering the price of was defined at P ∏ 0.05. There was no financial support from or any relationship with the producer of 16 mg of oral ondansetron. Regarding this, a considerably cheaper alternative to MTX and ondansetron ondansetron.
Two hundred and thirty-two patients diagnosed as may be to swap the patient over to an alternative having RA according to the ACR criteria have been DMARD. In conclusion, in RA, ondansetron seems treated with MTX in our unit since 1987. Nine of them to be useful and safe in preventing refractory and (4%) (seven women/two men) meeting the abovesevere nausea induced by MTX. A larger controlled mentioned inclusion criteria for use of ondansetron and blinded study is needed to support these promiswere studied. All of them had been on therapy with at ing results. least another DMARD before starting MTX. Patients were observed within the 4 weeks before the onset of ondansetron therapy. At baseline, the intensity of elbow was explored with a needle, but no pus was S. aureus sensitive to those antibiotics. The injection in case 3 was just 9 days after the injection which had infected case 2.
Three Infected Injections from the Same Organism
After the third infection, nasal swabs were taken SRheumatologists perform injections daily in the from the operator (MFG) and from case number 2. normal routine of treatment. These injections carry a MFG yielded S. aureus sensitive to erythromycin, tiny risk of infection, quoted as 0.06% for arthrocentflucloxacillin and penicillin. The swab from case 2 was esis [1]. This risk can presumably be minimized by negative. Phage typing was performed on staphylococci reasonable sterile precautions, but practice in this grown from all three infections and from the nasal respect varies widely [2] . I wish to report three cases swab of MFG. These were all identical. MFG then of infection from the same phage type Staphylococcus undertook a week's course of standard treatment for which was present in the operator's nostrils. staphylococcal carriers. Further nasal swabs taken then Case 1 was a woman aged 34 yr with a prolapsed and subsequently were negative. lumbar disc with sciatica. She was treated with three These injections were all undertaken using the modsacral epidural injections of 40-60 mg of triamcinolone erately rigorous, but not totally aseptic, technique acetonide in 20 ml of 0.25% lignocaine, with 2 months which the author had used for many years. This and then 3 weeks between injections. Three weeks after involved careful hand washing, the use of sterile towels the third injection, she was admitted to hospital with upon which to place prepared syringes, etc., and prior fever and a considerable increase in pain in the back swabbing of the skin with Mediswabs. On microbioand left leg. ESR was 78 mm, WBC 15.4 × 109/l with logical advice, this technique has now been improved 72% neutrophils. Liver function tests were abnormal.
by the invariable use of disposable sterile gloves, and A small amount of thick pus was withdrawn by needle careful preliminary drying of the injection site. Medical puncture of a tender swelling at the left low back. This accidents such as infections cannot be eliminated comyielded a heavy growth of Staphylococcus aureus sensitpletely, and it is not known whether the incidence of ive to most antibiotics. Appropriate antibiotics were infection is altered by the level of aseptic technique given and an MRI scan showed a paravertebral muscle [2] . Skin disinfectants have proven efficacy and are abscess with the suspicion of infection within the recommended [3], although no difference on microbiolumbar epidural space. logical testing of the skin has been shown after using At operation by Mr Robert Bradford, neurosurgdifferent forms of skin swab [4] . eon, a large left paravertebral muscle abscess was
The presence of pathogenic Staphylococcus in the drained, but fortunately the epidural space was free nose of an operator performing invasive techniques from infection. The patient made an uneventful can have dangerous consequences. Perhaps regular recovery.
checking of doctors performing such techniques should It seems likely that the second injection caused the be performed, but this is not routine practice and it is infection, after which some deterioration occurred.
doubtful whether the yield would make this worthCase 2 was a 63-yr-old woman with an ulnar comwhile. The three patients reported here were not ill or pression neuropathy at the elbow who was given an immunocompromised, but were otherwise healthy injection of 25 mg of hydrocortisone acetate to the people. The risk of introducing infection, and the ulnar groove. Within 4 days, she developed swelling necessity to consider this diagnosis in the event of and pain above the injected area, fever, and increased untoward reactions to injections, must constantly be ulnar nerve dysfunction. A diffuse tender swelling borne in mind. I would like to thank Dr Yasmin Drabu for her proximal to the ulnar groove in the muscles above the
